| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9940653 | American Journal of Hypertension | 2005 | 8 Pages |
Abstract
The blood pressure-lowering effect of this triple VPI was superior to that of the other VPI in this preclinical rat model of hypertension. Further experiments are needed to assess triple VPI to other combinations in other models with regard to efficacy and angioedema. Only then it may constitute a first-in-class approach for the treatment of hypertension and other cardiovascular disorders.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Philippe Daull, Ouhida Benrezzak, Dominique Arsenault, Leng Hong Pheng, André Blouin, Julie Cayer, Myriam Beaudoin, Karine Belleville, Pierre Sirois, François Nantel, Arco Y. Jeng, Bruno Battistini,